title: Long-term prophylactic antiviral therapy for recurrent herpes simplex: the controversy goes on.
authors.affiliation: Dermatology Unit, Kaplan Medical Center, Rechovot, Israel. wolf_r@netvision.net.il
authors.forename: Ronni
authors.initials: R
authors.lastname: Wolf
authors.forename: Danny
authors.initials: D
authors.lastname: Wolf
authors.forename: Edith
authors.initials: E
authors.lastname: Orion
authors.forename: Hagit
authors.initials: H
authors.lastname: Matz
mesh_terms: D000212:Acyclovir / Q000009:adverse effects / Q000627:therapeutic use*; D000998:Antiviral Agents / Q000009:adverse effects / Q000627:therapeutic use*; D004305:Dose-Response Relationship, Drug; D004334:Drug Administration Schedule; D064420:Drug-Related Side Effects and Adverse Reactions; D005260:Female; D005500:Follow-Up Studies; D006561:Herpes Simplex / Q000188:drug therapy* / Q000517:prevention & control*; D006801:Humans; D008134:Long-Term Care; D008297:Male; D012008:Recurrence; D018570:Risk Assessment; D012307:Risk Factors; D012720:Severity of Illness Index
chemical_list: D000998:Antiviral Agents; D000212:Acyclovir